HOME >> BIOLOGY >> NEWS
Joslin study reveals how a specific fat type can protect against weight gain and diabetes

BOSTON March 1, 2007 -- A new study from Joslin Diabetes Center may shed light on why some people can eat excessive amounts of food and not gain weight or develop type 2 diabetes, while others are more likely to develop obesity and this most common form of diabetes on any diet. The study, which used two strains of mice with differing tendencies to gain weight and develop diabetes on a high-fat diet, identified genetic and cellular mechanisms that may prevent certain mice on a calorie-dense diet from gaining weight and developing metabolic syndrome.

Although this study was done with mice, it points out new mechanisms that may underlie the ability of genetically different mice -- and perhaps genetically different people -- to not gain much weight on high caloric diets, said lead investigator C. Ronald Kahn, M.D., an internationally recognized researcher who is Head of Joslins Section on Obesity and Hormone Action and the Mary K. Iacocca Professor of Medicine at Harvard Medical School.

The study, published in the online edition of the Proceedings of the National Academy of Sciences on Feb. 5-9, builds upon years of research at Joslin and elsewhere on energy metabolism and the genetics of fat cells.

It has long been known that people significantly differ in their tendency to gain weight and develop metabolic syndrome, a group of conditions including hypertension, abdominal obesity, high triglycerides and glucose intolerance that can lead to type 2 diabetes. More than 60 million Americans either are obese or have metabolic syndrome, putting them at risk for type 2 diabetes and its frequent complications, including cardiovascular disease and other serious conditions. Currently 21 million Americans have diabetes and approximately one-third of them do not even know they have the disease. Formerly known as adult-onset diabetes, type 2 diabetes is occurring more frequently in young adults and even children.

Previous studies at
'"/>

Contact: Marjorie Dwyer
marjorie.dwyer@joslin.harvard.edu
617-732-2415
Joslin Diabetes Center
1-Mar-2007


Page: 1 2 3

Related biology news :

1. Joslin study indicates insulin receptors play a critical role in promoting islet growth
2. Joslin researchers discover a surprising culprit in the search for causes of diabetic birth defects
3. Joslin discovers protein that causes blood vessel leakage and swelling with diabetic retinopathy
4. Joslin-led study uncovers role of appetite hormone MCH in insulin production
5. Joslin Diabetes Center study examines insulin pump therapy in adolescents
6. Joslin Diabetes Center in Boston establishes first affiliate in Canada
7. Walgreens and Joslin Diabetes Center form broad alliance to improve diabetes outcomes
8. Joslin awards Victory Medal to New York man living 75 years with type 1 diabetes
9. Joslins new book demystifies nutrition and meal planning for people with diabetes
10. Joslin study refutes recent report that bone marrow can replenish female oocytes
11. Joslin discovers signs of residual islet cell function in people with long-term type 1 diabetes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/8/2019)... (PRWEB) , ... January 07, 2019 , ... ... micro mechanical technologies and solutions for hearing instruments and specialty earphones, and ... the first ever hearing aid receiver in canal with an embedded biometric sensor. ...
(Date:1/5/2019)... TORONTO (PRWEB) , ... January 04, 2019 , ... ... Chief Architect – two experts in Healthcare & Life Sciences from MarkLogic – ... EST (4pm GMT). , This presentation outlines the challenges of using real world ...
(Date:1/4/2019)... ... ... Stay on top of current hot topics through free webinars presented by leading experts ... so be sure to register today to save your place! Participate in the discussion ... upcoming webinars, or click below to learn more about each webinar: , CLINICAL TRIALS, ...
Breaking Biology News(10 mins):
(Date:1/7/2019)... , ... January 07, 2019 , ... ... clinical trials of its Parkinson's Disease drug candidate, code-named "KM-819." KM-819 is ... Disease. The trial took place in South Korea. , This Phase 1 ...
(Date:12/20/2018)... ... December 20, 2018 , ... New Year’s brings reflection and desire to ... in the European Union (EU) on the horizon, Jim Kasic, president and CEO of ... to the EU Medical Device Regulation (MDR), digital health, and big data are just ...
(Date:12/18/2018)... LOMA LINDA, Calif. (PRWEB) , ... December 18, 2018 , ... ... treatment after a lumpectomy have better quality of life post-treatment versus whole breast irradiation, ... to two — are typically treated with whole breast irradiation after removal of the ...
(Date:12/13/2018)... ... December 13, 2018 , ... Microbial Discovery Group LLC ... has been part of their strategic plan and an important milestone in increasing ... fermentation opportunities for MDG within the $44 Billion human probiotic market. This plan ...
Breaking Biology Technology:
Cached News: